InvestorsHub Logo
Followers 1
Posts 187
Boards Moderated 0
Alias Born 02/10/2017

Re: hardcore post# 8083

Tuesday, 06/02/2020 5:23:02 PM

Tuesday, June 02, 2020 5:23:02 PM

Post# of 8299
That was my thought. The P2 was run by a Dr. that sits on the FDA Advisory board for Cardiac. P2 was stat sig with 37 patients. The indication is billions and billions per year in revenue.

I get it not a P3 but in my opinion P2 results in heart studies are much more predictive or actual results than in oncology.

Drug cost $180MM to get to this stage.

Drug already approved in other countries.

Just mind blowing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TENX News